Dianthus Therapeutics, Inc. (DNTH)
103.91
-0.86
(-0.82%)
USD |
NASDAQ |
Sep 16, 14:33
Dianthus Therapeutics Price to Book Value : 4.858 for Sept. 16, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 4.898 |
| September 14, 2026 | 5.035 |
| September 11, 2026 | 4.965 |
| September 10, 2026 | 4.829 |
| September 09, 2026 | 5.005 |
| September 08, 2026 | 5.102 |
| September 04, 2026 | 5.054 |
| September 03, 2026 | 5.043 |
| September 02, 2026 | 4.967 |
| September 01, 2026 | 4.985 |
| August 31, 2026 | 4.938 |
| August 28, 2026 | 4.949 |
| August 27, 2026 | 5.215 |
| August 26, 2026 | 5.179 |
| August 25, 2026 | 5.242 |
| August 24, 2026 | 5.146 |
| August 21, 2026 | 5.194 |
| August 20, 2026 | 5.120 |
| August 19, 2026 | 5.316 |
| August 18, 2026 | 5.402 |
| August 17, 2026 | 5.370 |
| August 14, 2026 | 5.422 |
| August 13, 2026 | 5.124 |
| August 12, 2026 | 5.256 |
| August 11, 2026 | 5.072 |
| Date | Value |
|---|---|
| August 10, 2026 | 5.227 |
| August 07, 2026 | 5.093 |
| August 06, 2026 | 5.139 |
| August 05, 2026 | 5.26 |
| August 04, 2026 | 5.162 |
| August 03, 2026 | 4.957 |
| July 31, 2026 | 4.999 |
| July 30, 2026 | 5.266 |
| July 29, 2026 | 4.867 |
| July 28, 2026 | 4.751 |
| July 27, 2026 | 4.886 |
| July 24, 2026 | 4.856 |
| July 23, 2026 | 4.900 |
| July 22, 2026 | 4.805 |
| July 21, 2026 | 4.943 |
| July 20, 2026 | 4.722 |
| July 17, 2026 | 4.937 |
| July 16, 2026 | 4.458 |
| July 15, 2026 | 4.671 |
| July 14, 2026 | 4.735 |
| July 13, 2026 | 4.612 |
| July 10, 2026 | 4.563 |
| July 09, 2026 | 4.677 |
| July 08, 2026 | 4.585 |
| July 07, 2026 | 4.477 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Verastem, Inc. | 13.29 |
| AbbVie, Inc. | -- |
| TG Therapeutics, Inc. | 14.17 |
| Krystal Biotech, Inc. | 7.435 |
| Legend Biotech Corp. | 2.676 |
Price to Book Value Related Metrics
| PS Ratio | 2549.01 |
| PEG Ratio | -0.9078 |
| Price | 103.91 |
| Earnings Yield | -4.00% |
| Market Cap | 5.694B |
| PEGY Ratio | -0.9078 |